Session topics

Session I

Informed Consent Process and Regulations

9:30 - 9:45 AM

Informed Consent Process in India and Patient Experience

Mr. Dan McDonald
Vice President Business Strategies
Excel Life Science, USA

9:50 - 10:10 AM

Understand How US FDA Reviewers Work and Think

Professor Joshua Sharlin, PhD
President, FDA Smart Inc., Former US FDA Drug Reviewers, Washington, DC. World Class trainer to over 3500 attendance during the last 10 years on mission critical topics to deliver US FDA regulatory compliance Master Consultant to Global Pharmaceutical, Biotech Biologics and Medical Devices Companies.

Session II

Session III

Session IV

Business Opportunities

3:40 - 4:00 PM

Outsourcing Opportunities - Business Partnership in
Clinical Research

Drug Development: Ethics and Public Confidence is a Must

Dr. Larisa Singh
Director,
ICON, India

4:00 - 4:20 PM

Export of Biological Samples During Clinical Trial

Dr. Sangha Mitra Patnaik, MD
Director, Global Regulatory Operations
Global Regulatory Affairs
Quintiles Global CRO, India

4:20 - 4:40 PM

Insurance of Clinical Trials

Dr. Volkar Kraus
Risk Consultant
Munich - Re, Germany

Mr. Richard Wulff
Chief Underwriting Officer
HDFC ERGO General Insurance

4:40 - 5:00 PM

Language Translation - Adding Value to
Clinical Research Industry

Mr. A. Gururaj
Director,
Value Point, India

5:00 - 5:20 PM

Clinical Trial and Research Industry 3:20 - 3:40 PM Evening Refreshment

Mr. Bipin Desai
Director,
Connexions India